FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2087466857> ?p ?o ?g. }

• W2087466857 endingPage "185" @default.
• W2087466857 startingPage "179" @default.
• W2087466857 abstract "1. RB 101, a complete inhibitor of enkephalin-catabolizing enzymes, has been previously shown to produce antinociception in normal rats after systemic administration. Moreover, its coadministration with a cholecystokinin-B (CCK-B) receptor antagonist has been shown to strongly enhance its antinociceptive effect in normal rats. In this work, we determined whether RB 101 was able to reduce hyperalgesia and allodynia in diabetic rats, a model of neuropathic pain. The type of opioid receptors (mu or delta) involved was determined using naloxone and naltrindole, respectively, and the interactions between endogenous enkephalins and CCK on nociception control was investigated using coadministration of RB 101 and the CCK-B receptor antagonist CI-988. 2. RB 101 suppressed mechanical hyperalgesia (paw pressure-induced vocalization test), partially alleviated mechanical allodynia (von Frey hair test), and was ineffective in thermal allodynia (tail immersion test). The analgesic effect was completely cancelled by naloxone or naltrindole, suggesting that is requires the availability of mu- and/or delta-opioid receptors. 3. The combination of an inactive dose of CI-988 with the lowest effective dose of RB 101 resulted in a stronger increase in the vocalization threshold comparatively to RB 101 alone. 4. The present study demonstrates that the antinociception generated by RB 101 induced by elevation of extracellular levels of endogenous enkephalins, can be extended to neuropathic pain in diabetic rats and that blockade of CCK-B receptors potentiated antinociceptive effects elicited by RB 101." @default.
• W2087466857 created "2016-06-24" @default.
• W2087466857 creator A5032132304 @default.
• W2087466857 creator A5053039277 @default.
• W2087466857 creator A5068784944 @default.
• W2087466857 creator A5075478051 @default.
• W2087466857 creator A5084898621 @default.
• W2087466857 creator A5089130062 @default.
• W2087466857 date "2001-05-01" @default.
• W2087466857 modified "2023-10-18" @default.
• W2087466857 title "Enhancement of the effects of a complete inhibitor of enkephalin-catabolizing enzymes, RB 101, by a cholecystokinin-B receptor antagonist in diabetic rats" @default.
• W2087466857 cites W1903127408 @default.
• W2087466857 cites W1945968231 @default.
• W2087466857 cites W1966506533 @default.
• W2087466857 cites W1979100850 @default.
• W2087466857 cites W1982781804 @default.
• W2087466857 cites W1986741071 @default.
• W2087466857 cites W1993807039 @default.
• W2087466857 cites W1998534899 @default.
• W2087466857 cites W2005286314 @default.
• W2087466857 cites W2012797719 @default.
• W2087466857 cites W2015549509 @default.
• W2087466857 cites W2019952711 @default.
• W2087466857 cites W2027119507 @default.
• W2087466857 cites W2027389030 @default.
• W2087466857 cites W2043323520 @default.
• W2087466857 cites W2053769278 @default.
• W2087466857 cites W2058315281 @default.
• W2087466857 cites W2069886558 @default.
• W2087466857 cites W2070370133 @default.
• W2087466857 cites W2083277759 @default.
• W2087466857 cites W2084478012 @default.
• W2087466857 cites W2087454739 @default.
• W2087466857 cites W2117659611 @default.
• W2087466857 cites W2123281693 @default.
• W2087466857 cites W2125350295 @default.
• W2087466857 cites W2148367885 @default.
• W2087466857 cites W2164872793 @default.
• W2087466857 cites W2167243738 @default.
• W2087466857 cites W2224591143 @default.
• W2087466857 cites W2256167805 @default.
• W2087466857 cites W2288638425 @default.
• W2087466857 cites W2765376853 @default.
• W2087466857 doi "https://doi.org/10.1038/sj.bjp.0704059" @default.
• W2087466857 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/1572770" @default.
• W2087466857 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/11325808" @default.
• W2087466857 hasPublicationYear "2001" @default.
• W2087466857 type Work @default.
• W2087466857 sameAs 2087466857 @default.
• W2087466857 citedByCount "18" @default.
• W2087466857 countsByYear W20874668572012 @default.
• W2087466857 countsByYear W20874668572013 @default.
• W2087466857 countsByYear W20874668572020 @default.
• W2087466857 crossrefType "journal-article" @default.
• W2087466857 hasAuthorship W2087466857A5032132304 @default.
• W2087466857 hasAuthorship W2087466857A5053039277 @default.
• W2087466857 hasAuthorship W2087466857A5068784944 @default.
• W2087466857 hasAuthorship W2087466857A5075478051 @default.
• W2087466857 hasAuthorship W2087466857A5084898621 @default.
• W2087466857 hasAuthorship W2087466857A5089130062 @default.
• W2087466857 hasBestOaLocation W20874668572 @default.
• W2087466857 hasConcept C126322002 @default.
• W2087466857 hasConcept C134018914 @default.
• W2087466857 hasConcept C15490471 @default.
• W2087466857 hasConcept C170493617 @default.
• W2087466857 hasConcept C185592680 @default.
• W2087466857 hasConcept C2776885963 @default.
• W2087466857 hasConcept C2777593968 @default.
• W2087466857 hasConcept C2777803847 @default.
• W2087466857 hasConcept C2777883359 @default.
• W2087466857 hasConcept C2777953665 @default.
• W2087466857 hasConcept C2778122271 @default.
• W2087466857 hasConcept C2778750930 @default.
• W2087466857 hasConcept C2779245659 @default.
• W2087466857 hasConcept C2779886867 @default.
• W2087466857 hasConcept C2781063702 @default.
• W2087466857 hasConcept C3017995582 @default.
• W2087466857 hasConcept C32110497 @default.
• W2087466857 hasConcept C55493867 @default.
• W2087466857 hasConcept C71924100 @default.
• W2087466857 hasConcept C98274493 @default.
• W2087466857 hasConceptScore W2087466857C126322002 @default.
• W2087466857 hasConceptScore W2087466857C134018914 @default.
• W2087466857 hasConceptScore W2087466857C15490471 @default.
• W2087466857 hasConceptScore W2087466857C170493617 @default.
• W2087466857 hasConceptScore W2087466857C185592680 @default.
• W2087466857 hasConceptScore W2087466857C2776885963 @default.
• W2087466857 hasConceptScore W2087466857C2777593968 @default.
• W2087466857 hasConceptScore W2087466857C2777803847 @default.
• W2087466857 hasConceptScore W2087466857C2777883359 @default.
• W2087466857 hasConceptScore W2087466857C2777953665 @default.
• W2087466857 hasConceptScore W2087466857C2778122271 @default.
• W2087466857 hasConceptScore W2087466857C2778750930 @default.
• W2087466857 hasConceptScore W2087466857C2779245659 @default.
• W2087466857 hasConceptScore W2087466857C2779886867 @default.
• W2087466857 hasConceptScore W2087466857C2781063702 @default.
• W2087466857 hasConceptScore W2087466857C3017995582 @default.
• W2087466857 hasConceptScore W2087466857C32110497 @default.

• next